FR2378855A1 - Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments - Google Patents

Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments

Info

Publication number
FR2378855A1
FR2378855A1 FR7702267A FR7702267A FR2378855A1 FR 2378855 A1 FR2378855 A1 FR 2378855A1 FR 7702267 A FR7702267 A FR 7702267A FR 7702267 A FR7702267 A FR 7702267A FR 2378855 A1 FR2378855 A1 FR 2378855A1
Authority
FR
France
Prior art keywords
hafnia
preparation
application
medicinal products
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7702267A
Other languages
English (en)
Other versions
FR2378855B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassenne Laboratoires
Original Assignee
Cassenne Laboratoires
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassenne Laboratoires filed Critical Cassenne Laboratoires
Priority to FR7702267A priority Critical patent/FR2378855A1/fr
Priority to US05/871,408 priority patent/US4154821A/en
Priority to DE19782803001 priority patent/DE2803001A1/de
Priority to IE183/78A priority patent/IE46195B1/en
Priority to CA295,753A priority patent/CA1092041A/fr
Priority to GB3219/78A priority patent/GB1567106A/en
Priority to BE184666A priority patent/BE863359A/fr
Priority to DK037578A priority patent/DK150497C/da
Priority to LU78953A priority patent/LU78953A1/fr
Priority to CH93478A priority patent/CH639395A5/fr
Priority to JP745178A priority patent/JPS5396000A/ja
Priority to NL7801024A priority patent/NL7801024A/xx
Publication of FR2378855A1 publication Critical patent/FR2378855A1/fr
Application granted granted Critical
Publication of FR2378855B1 publication Critical patent/FR2378855B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/275—Hafnia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Abstract

Nouvelles glycoprotéines hydrosolubles, caractérisées en ce qu'elles sont extraites de corps microbiens lyses d'Hafnia et en ce qu'elles possèdent un poids moléculaire apparent égal ou supérieur à 300.000. Procédé de préparation et application à titre de médicaments de ces nouveaux produits.
FR7702267A 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments Granted FR2378855A1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR7702267A FR2378855A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments
US05/871,408 US4154821A (en) 1977-01-27 1978-01-23 Novel glycoproteins
DE19782803001 DE2803001A1 (de) 1977-01-27 1978-01-24 Neue aus hafnia isolierte glykoproteine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
CA295,753A CA1092041A (fr) 1977-01-27 1978-01-26 Procede de preparation de nouvelles glycoproteines isolees d'hafnia
GB3219/78A GB1567106A (en) 1977-01-27 1978-01-26 Microbial fractions
BE184666A BE863359A (fr) 1977-01-27 1978-01-26 Nouvelles glycoproteines isolees d'hafnia, procede de preparation et compositions pharmaceutiques
IE183/78A IE46195B1 (en) 1977-01-27 1978-01-26 Microbial fractions
DK037578A DK150497C (da) 1977-01-27 1978-01-26 Fremgangsmaade til fremstilling af vandoploeselige glycoproteiner med betaendelseshaemmende og immunostimulerende virkning
LU78953A LU78953A1 (fr) 1977-01-27 1978-01-26 Procede de preparation de nouvelles glycoproteines isolees d'hafnia
CH93478A CH639395A5 (fr) 1977-01-27 1978-01-27 Glycoproteines constitutives d'hafnia, procede de preparation et compositions pharmaceutiques.
JP745178A JPS5396000A (en) 1977-01-27 1978-01-27 Novel glycoprotein separating from hafnia genus process for preparing same and pharmaceutical composition
NL7801024A NL7801024A (nl) 1977-01-27 1978-01-27 Nieuwe uit hafnia geisoleerde glysoproteinen, werkwijze voor hun bereiding en farmaceutische preparaten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7702267A FR2378855A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments

Publications (2)

Publication Number Publication Date
FR2378855A1 true FR2378855A1 (fr) 1978-08-25
FR2378855B1 FR2378855B1 (fr) 1979-05-11

Family

ID=9185964

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7702267A Granted FR2378855A1 (fr) 1977-01-27 1977-01-27 Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments

Country Status (12)

Country Link
US (1) US4154821A (fr)
JP (1) JPS5396000A (fr)
BE (1) BE863359A (fr)
CA (1) CA1092041A (fr)
CH (1) CH639395A5 (fr)
DE (1) DE2803001A1 (fr)
DK (1) DK150497C (fr)
FR (1) FR2378855A1 (fr)
GB (1) GB1567106A (fr)
IE (1) IE46195B1 (fr)
LU (1) LU78953A1 (fr)
NL (1) NL7801024A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
GB2157566A (en) * 1984-04-26 1985-10-30 Roussel Uclaf Cosmetic compositions containing lysed extracts of hafnia
FR2648351A1 (fr) * 1989-06-20 1990-12-21 Roussel Uclaf Utilisation de complexes glycoproteiques extraits de bacteries gram(-) pour la fabrication d'un medicament facilitant la cicatrisation de la peau et procede de preparation

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4313934A (en) * 1979-05-08 1982-02-02 Kirin Beer Kabushiki Kaisha Physiologically active polysaccharides, production and uses thereof
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4503149A (en) * 1983-06-06 1985-03-05 Conoco Inc. Method of microbial assay
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1046770A (en) * 1963-05-14 1966-10-26 James Harrison Stanton Therapeutic composition containing mycelial matter
GB1186184A (en) * 1966-03-23 1970-04-02 Nat Res Dev Improvements in or relating to Separation Apparatus.
US3855197A (en) * 1969-05-20 1974-12-17 Cassenne Lab Sa Glycoproteins extracted from microorganisms
US3716452A (en) * 1970-09-17 1973-02-13 Kirin Brewery Lysis of yeast cell walls
FR2160326B1 (fr) * 1971-11-19 1975-02-07 Anvar
GB1426042A (en) * 1971-11-26 1976-02-25 Anvar water-soluble immunological adjuvants
US4032663A (en) * 1971-12-14 1977-06-28 Kumiai Chemical Industry Co., Ltd. Process for using cell wall-lysing enzymes
FR2184531B1 (fr) * 1972-05-19 1975-10-17 Anvar
US3868303A (en) * 1972-11-06 1975-02-25 Nat Food Res Method of producing enzyme and its utilization thereof
US3917510A (en) * 1973-04-11 1975-11-04 Kirin Brewery Lysis of yeast cell walls
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2269961B1 (fr) * 1974-05-06 1978-03-24 Anvar

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
EP0089266A1 (fr) * 1982-03-09 1983-09-21 Pierre Fabre S.A. Procédé de préparation de protéoglycanes immunostimulants inducteurs d'interféron, protéoglycanes obtenus et médicament les contenant
GB2157566A (en) * 1984-04-26 1985-10-30 Roussel Uclaf Cosmetic compositions containing lysed extracts of hafnia
FR2563431A1 (fr) * 1984-04-26 1985-10-31 Roussel Uclaf Nouvelles compositions cosmetiques renfermant des extraits lyses d'hafnia
DE3515231A1 (de) * 1984-04-26 1986-04-17 Roussel-Uclaf, Paris Kosmetische zusammensetzungen, die hafnia-extrakte enthalten
DE3515231C2 (de) * 1984-04-26 2000-03-16 Boots Co Plc Verwendung von Hafnia-Extrakten in kosmetischen Zusammensetzungen
FR2648351A1 (fr) * 1989-06-20 1990-12-21 Roussel Uclaf Utilisation de complexes glycoproteiques extraits de bacteries gram(-) pour la fabrication d'un medicament facilitant la cicatrisation de la peau et procede de preparation
EP0404660A2 (fr) * 1989-06-20 1990-12-27 Roussel-Uclaf Utilisation de complexes glycoprotéines extraits de bactéries gram (-) pour la fabrication d'un médicament facilitant la cicatrisation de la peau et procédé de préparation
EP0404660A3 (fr) * 1989-06-20 1991-12-04 Roussel-Uclaf Utilisation de complexes glycoprotéines extraits de bactéries gram (-) pour la fabrication d'un médicament facilitant la cicatrisation de la peau et procédé de préparation

Also Published As

Publication number Publication date
US4154821A (en) 1979-05-15
IE780183L (en) 1978-07-27
DK150497B (da) 1987-03-09
DK150497C (da) 1987-11-16
IE46195B1 (en) 1983-03-23
GB1567106A (en) 1980-05-08
LU78953A1 (fr) 1978-09-28
DK37578A (da) 1978-07-28
JPS6133840B2 (fr) 1986-08-04
DE2803001A1 (de) 1978-08-03
FR2378855B1 (fr) 1979-05-11
DE2803001C2 (fr) 1990-07-05
NL7801024A (nl) 1978-07-31
JPS5396000A (en) 1978-08-22
CA1092041A (fr) 1980-12-23
CH639395A5 (fr) 1983-11-15
BE863359A (fr) 1978-07-26

Similar Documents

Publication Publication Date Title
ES8802231A1 (es) Un procedimiento para extraer la sustancia quimica activa de la planta del aloe a partir de sus hojas
FI934849A0 (fi) Sammansaettningar foer foerhindrande och/eller behandlande av patologiskaprocesser
BR9607565A (pt) Derivados de hidroxilamina úteis para produção de protetores moleculares e sua preparação
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE17082T1 (de) Verfahren zur herstellung von polysaccharidprotein-komplexenaus bakterienhuellen, die hergestellten produkte und dieselben enthaltende immunogenische zusammensetzungen.
FR2378855A1 (fr) Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments
NO975366L (no) Vaksine sammensetning inneholdende polyribosylribitol fosfat og fremgangsmåte for fremstilling derav
DE69510669T2 (de) Modifizierter wachstumsfaktor der milch
BE884189A (fr) Nouveaux aryl-1 arylsulfonyl-4 gamma-aminopropoxy-3, 1h-pyrazoles, medicament en contenant et procede pour les preparer
FR2584727B1 (fr) Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
FR2407262A1 (fr) Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
FR2505185B1 (fr) Procede de preparation d'un polysulfate de chondroitine injectable, produit obtenu par ce procede et compositions pharmaceutiques le contenant
FR2448535A1 (fr) Nouveaux derives tricycliques et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
FR2381048A1 (fr) Nouveaux derives de 20,21-dinoreburnamenine, un procede pour leur preparation et leur application comme medicaments
BE874037A (fr) Procede de preparation d'inhibiteurs d'amylase, nouveaux produits ainsi obtenus et leurs utilisations pharmaceutiques, notamment pour combattre l'obesite et l'hyperglycemie
DE59404739D1 (de) Dextranester, verfahren zu ihrer herstellung und ihre verwendung zur umhüllung oder einbettung von arzneimitteln
ES8606898A1 (es) Un procedimiento para producir un factor regulador de cancerendogeno humano
BE877080A (fr) Nouveaux derives de la l-cysteine et leur application comme medicament, ainsi que composes intermediaires utiles pour leur procede de preparation
BE848004A (fr) Nouveaux derives d'imidazole, leur application en tant que medicamentset leur procede de preparation
FR2310765A1 (fr) Procede pour l'obtention de derives de 1,4-benzodiazepines substituees en position 2, nouveaux produits obtenus et leurs applications a titre de medicament
FR2417511A1 (fr) Derives de l'eburnamonine, leur preparation et medicaments contenant ces substances